Results 141 to 150 of about 62,434 (243)

Cancellous Autograft Transfer From Screw‐Hole to the Proximal Tibial Osteotomy Opening Gap for Early Bone Consolidation Without Donor‐Site Morbidity

open access: yesArthroscopy Techniques, EarlyView.
Abstract Autologous bone grafting can enhance gap healing after medial open‐wedge high tibial osteotomy and open‐wedge distal tibial tuberosity osteotomy, but iliac‐crest harvest adds donor‐site morbidity and is therefore not routinely performed. We describe a bone autografting technique, termed cancellous autograft transfer from screw‐hole, which ...
Yukio Akasaki   +5 more
wiley   +1 more source

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul   +7 more
wiley   +1 more source

ULTRA-MoCap: A Multimodal IMU and sEMG Dataset for Upper Body Joint Kinematics Analysis. [PDF]

open access: yesSci Data
Fritsche O   +8 more
europepmc   +1 more source

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim In the GENESECT study, no significant gemcitabine (GEM) metabolism‐related germline genetic polymorphisms (GPs) were identified because approximately 70% of patients received combination therapy with nab‐paclitaxel, which has metabolic pathways different from GEM.
Takashi Yokokawa   +21 more
wiley   +1 more source

IK SCHRIJF, DUS IK DENK

open access: yesDe Uil van Minerva, 2022
openaire   +1 more source

Drivers of Nature‐Related Investment Strategies Among Institutional Investors

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Institutional investors are increasingly responding to biodiversity loss through nature‐related investment strategies. Using survey data from 557 institutional investors, this study examines the drivers of strategy selection and how biodiversity risk is integrated across investor types, sizes, and regions.
Emma Olofsson
wiley   +1 more source

Addressing the Energy Trilemma: The Role of Entrepreneurship, Regulation, and Climate Finance

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Balancing energy security, energy equity, and environmental sustainability has become increasingly challenging as economies pursue low‐carbon growth amid climate risk and persistent disparities in access to modern energy. Although entrepreneurship is widely recognized as a driver of innovation, its role in addressing the energy trilemma ...
Kingsley Imandojemu   +3 more
wiley   +1 more source

A conserved bioelectrical signature defines subventricular zone-derived human fetal neural stem cells and tracks their differentiation state. [PDF]

open access: yesFront Cell Dev Biol
De Zio R   +9 more
europepmc   +1 more source

Asset Redeployability and Biodiversity Risk

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT We examine how asset redeployability influences a firm's exposure to biodiversity risk. Our empirical analysis provides robust evidence that firms possessing greater levels of redeployable assets exhibit significantly lower biodiversity risk.
Mostafa Monzur Hasan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy